These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26630653)

  • 1. Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy.
    Zhu X; Sun Q; Zou H; Xu X; Zhang X
    PLoS One; 2015; 10(12):e0143678. PubMed ID: 26630653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility Analysis of Vision-related Quality of Life in Patients With Glaucoma and Different Perceptions from Ophthalmologists.
    Zhang S; Liang Y; Chen Y; Musch DC; Zhang C; Wang N
    J Glaucoma; 2015 Sep; 24(7):508-14. PubMed ID: 25415642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility values associated with diabetic retinopathy in Chennai, India.
    Polack S; Alavi Y; Rachapalle Reddi S; Kulothungan V; Kuper H
    Ophthalmic Epidemiol; 2015 Feb; 22(1):20-7. PubMed ID: 24669801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility values and diabetic retinopathy.
    Brown MM; Brown GC; Sharma S; Shah G
    Am J Ophthalmol; 1999 Sep; 128(3):324-30. PubMed ID: 10511027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility assessment among patients of primary angle closure/glaucoma in China: a preliminary study.
    Sun X; Zhang S; Wang N; Liang Y; Wang L; Fan S; Sun L
    Br J Ophthalmol; 2009 Jul; 93(7):871-4. PubMed ID: 19208679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine.
    Finger RP; Hoffmann AE; Fenwick EK; Wolf A; Kampik A; Kernt M; Neubauer AS; Hirneiss C
    Br J Ophthalmol; 2012 Jul; 96(7):997-1002. PubMed ID: 22535331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health utility values associated with diabetic retinopathy.
    Lloyd A; Nafees B; Gavriel S; Rousculp MD; Boye KS; Ahmad A
    Diabet Med; 2008 May; 25(5):618-24. PubMed ID: 18346157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient preferences for diabetic retinopathy health States.
    Szabo SM; Beusterien KM; Pleil AM; Wirostko B; Potter MJ; Tildesley H; Gonder J; Barsdorf A; Levy AR
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3387-94. PubMed ID: 20053977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vision-related quality of life and visual outcomes from cataract surgery in patients with vision-threatening diabetic retinopathy: a prospective observational study.
    Zhu B; Ma Y; Lin S; Zou H
    Health Qual Life Outcomes; 2017 Sep; 15(1):175. PubMed ID: 28865457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain quality of life as measured by utilities.
    Wetherington S; Delong L; Kini S; Veledar E; Schaufele MK; McKenzie-Brown AM; Chen SC
    Pain Med; 2014 May; 15(5):865-70. PubMed ID: 24716656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rating scale is a proper method to evaluate changes in quality of life due to dry eye symptoms.
    Xue W; Xu X; Zou H
    Int Ophthalmol; 2019 Mar; 39(3):563-569. PubMed ID: 29417445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility values in patients with acquired anophthalmus.
    Hirneiss C; Neubauer AS; Herold TR; Kampik A; Hintschich C
    Orbit; 2009; 28(6):332-6. PubMed ID: 19929654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of persistent visually disabling vitreous floaters on health status utility values.
    Zou H; Liu H; Xu X; Zhang X
    Qual Life Res; 2013 Aug; 22(6):1507-14. PubMed ID: 23054488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between ophthalmologists' and patients' perceptions of quality of life associated with age-related macular degeneration.
    Brown GC; Brown MM; Sharma S
    Can J Ophthalmol; 2000 Apr; 35(3):127-33. PubMed ID: 10812481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.
    Brown MM; Brown GC; Sharma S; Landy J; Bakal J
    Arch Ophthalmol; 2002 Apr; 120(4):481-4. PubMed ID: 11934322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.